Cours suspendu

Communiqués SOCL CAP

Actions

DNAA

KYG8253T1067

Marché Fermé - Nasdaq 22:00:00 01/07/2024			Varia. 5j.	Varia. 1 janv.
0,4320 ^USD	-0,62%		-.--%	-90,51%

19/08/22	Akili Interactive Labs, Inc. a réalisé l'acquisition de Social Capital Suvretta Holdings Corp. I (NasdaqCM:DNAA) (SCS) auprès de SCS Sponsor I LLC, Adage Capital Management, L.P., Citadel Advisors LLC, Millennium Management LLC et autres dans le cadre d'une opération de fusion inversée.	CI
12/08/22	Capital social Suvretta Holdings Corp. I annonce ses résultats pour le deuxième trimestre et le semestre clos le 30 juin 2022	CI

Communiqués

25/08/22	SOCL CAP : AUG 2022 - Form 8-K	PU
23/08/22	SOCL CAP : Notes To The Condensed Consolidated Financial Statements - Form 8-K	PU
19/08/22	AKILI, INC. : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
12/08/22	SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. I Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	AQ
08/07/22	SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. I : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	AQ
20/05/22	SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. I Other Events, Financial Statements and Exhibits (form 8-K/A)	AQ
20/05/22	Social Capital Suvretta I : REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - Form 8-K/A	PU
17/05/22	SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. I Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	AQ
22/04/22	SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. I : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	AQ
04/04/22	Akili to Present at Chardan’s Prescription Digital Therapeutics Half-Day Summit	BU
24/03/22	SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. I Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	AQ
17/03/22	Game Industry Veteran Behind Bejeweled, Plants vs. Zombies Joins Akili as Chief Product Officer	BU
10/03/22	Akili to Speak at SXSW 2022 on Building a New Class of Disease-Modifying Digital Therapeutics	BU
08/03/22	Akili Named to Fast Company’s Annual List of the World’s 50 Most Innovative Companies for 2022	BU
07/03/22	Akili to Present at Cowen’s 42nd Annual Health Care Conference	BU
18/02/22	Akili to Speak on Integrating Digital Therapeutics Into Mainstream Healthcare at DTx West 2022	BU
17/02/22	PLOS ONE Publishes Clinical Study Results and EEG Data Showing Akili Digital Therapeutic EndeavorRx® Activates Systems in Brain Key to Attentional Functioning	BU
14/02/22	Akili Interactive Announces Filing of Registration Statement on S-4 in Connection with its Proposed Business Combination with Social Capital Suvretta Holdings Corp. I	BU
27/01/22	Social Capital Suvretta I : Consolidated Financial Statements - Form 8-K/A	PU
27/01/22	SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. I Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K/A)	AQ
27/01/22	BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Social Capital Suvretta Holdings Corp. I (Nasdaq - DNAA), Arisz Acquisition Corp. (Nasdaq - ARIZ), Sports Ventures Acquisition Corp. (Nasdaq - AKIC)	PR
26/01/22	Social Capital Suvretta I : Akili Interactive, a Leader in Digital Medicine, to Become Publicly Traded Through Combination with Social Capital Suvretta Holdings Corp. I - Form 8-K	PU
26/01/22	SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. I : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
26/01/22	Akili Interactive, a Leader in Digital Medicine, to Become Publicly Traded Through Combination with Social Capital Suvretta Holdings Corp. I	BU
16/11/21	SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. I : Non-Reliance on Previous Financials, Audits or Interim Review (form 8-K)	AQ